Companies: 10,795·Total market cap: $144.5T
Coya Therapeutics, Inc.

Coya Therapeutics, Inc.

COYANASDAQHealthcare● Active
$4.55
+$0.13(+2.94%)
Market Cap$82849822
P/E Ratio
52W High$7.75
52W Low$3.71

Coya Therapeutics, Inc.(COYA)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · COYA · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$7.95M$3.55M$6.00M$0.00M$0.00M
Cost of Revenue$0.03M$11.87M$5.50M$4.41M$0.00M
Gross Profit$7.92M($8.31M)$0.50M($4.41M)$0.00M
Gross Margin %(computed)99.66%-233.86%8.34%
Operating Expenses
R&D Expenses$16.73M$11.89M$6.04M$4.94M$2.54M
G&A Expenses$11.45M$8.89M$7.83M$4.85M$2.31M
Total Operating Expenses$28.18M$8.94M$8.40M$5.40M$4.87M
Operating Income($20.27M)($17.25M)($7.90M)($9.81M)($4.87M)
Operating Margin %(computed)-255.05%-485.35%-131.67%
Interest Income$0.00M$0.00M$0.00M$0.00M$0.00M
Interest Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Income Before Tax($21.22M)($15.60M)($7.26M)($12.24M)($4.89M)
Income Tax Expense$0.00M($0.72M)$0.72M$0.00M$0.00M
Net Income($21.23M)($14.88M)($7.99M)($12.24M)($4.89M)
Net Margin %(computed)-267.14%-418.70%-133.08%
Per Share & EBITDA
EPS (Basic)$-1.27$-0.98$-0.79$-1.23$-0.74
Wtd Avg Shares16.73M15.24M10.16M9.95M6.60M
EBITDA($20.24M)($17.20M)($7.33M)($9.26M)($4.85M)
EBITDA Margin %(computed)-254.71%-483.88%-122.17%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Coya Therapeutics, Inc.

关于Coya Therapeutics, Inc.(COYA)损益表

Coya Therapeutics, Inc.(COYA)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,COYA实现营收$0.01B,毛利润$0.01B(毛利率99.66%),净利润($0.02B)(净利率-267.14%)。

常见问题

COYA · 4 问

Coya Therapeutics, Inc.(COYA)2025财年营收为$0.01B,同比up123.6%。

COYA revenueCOYA salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09